EurekAlert! News by Subject: Medicine & Health - News by Subject: Medicine & Health

Medicine & Health

Updates every hour. Last Updated: 30-Jun-2025 13:10 ET (30-Jun-2025 17:10 GMT/UTC)

HER2-mutated NSCLC in Brazil shows diverse genetic patterns and treatment gaps

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY – June 27, 2025 – A new research paper was published in Volume 16 of Oncotarget on June 17, 2025, titled “Molecular landscape of HER2-mutated non-small cell lung cancer in Northeastern Brazil: Clinical, histopathological, and genomic insights.”

Journal: Oncotarget

Majority of Medicaid managed care plans cover opioid overdose reversal drug naloxone

Boston University School of Public Health
Peer-Reviewed Publication

A new study in JAMA Network Open found that almost all Medicaid managed care plans (MCPs) cover at least one of the four formulations of naloxone. Eighty percent of Medicaid recipients, which include more than 70 million people, are enrolled in these plans. The study is the first to assess naloxone coverage within MCPs.

Journal: JAMA Network Open
Funder: National Institute on Drug Abuse

Dr. Dae Hyun Kim named to Lancet Commission on Frailty

Hebrew SeniorLife Hinda and Arthur Marcus Institute for Aging Research
Business Announcement

Dae Hyun Kim, MD, MPH, ScD, has joined a new Lancet Commission on Frailty, as part of an effort by one of the world’s most influential peer-reviewed medical journals to globally reorient frailty in clinical practice, public health, and policy. An associate director and senior scientist at Hebrew SeniorLife’s Hinda and Arthur Marcus Institute for Aging Research, Dr. Kim joins 20 other global experts to bring a multidisciplinary perspective to developing strategies that can be adapted to populations with disparities in access to care.

Verify the therapeutic effect of effective components of lycium barbarum on hepatocellular carcinoma based on molecular docking

Xia & He Publishing Inc.
Peer-Reviewed Publication

In recent years, it has been found that Lycium barbarum can repair liver damage and promote liver regeneration. Additionally, the polysaccharides contained in Lycium barbarum have anticancer properties and can induce apoptosis in cancer cells. Molecular docking, a mature computer-aided method, is widely used in drug discovery. This study aimed to verify the efficacy of active ingredients of Lycium barbarum in the treatment of liver cancer by molecular docking.

Journal: Oncology Advances

Precision oncology Organ Chip platform accurately and actionably predicts chemotherapy responses of patients suffering from esophageal adenocarcinoma

Wyss Institute for Biologically Inspired Engineering at Harvard
Peer-Reviewed Publication

Esophageal adenocarcinoma (EAC) is the sixth most deadly cancer worldwide for which no effective targeted therapy exists. Patients need to rely on chemotherapy which is started ahead of surgical interventions in the hope to shrink or control tumors. However, most patients become resistant to certain NACTs, leading to poor outcomes.

To enable clinicians to rapidly test different chemotherapies and determine the best treatment courses, Wyss Institute researchers and their collaborators at McGill University have developed a precision oncology Organ Chip platform that accurately and actionably predicts chemotherapy responses of individual patients with EAC in a clinically useful timeframe.

Journal: Journal of Translational Medicine

Early 20th century closures of US medical schools resulted in drops in infant mortality, non-infant mortality, and total mortality

Carnegie Mellon University
Reports and Proceedings

Efforts in the early 20th century to improve the quality of medical education in the United States led to a steep decline in the number of medical schools and medical school graduates. In a new study, researchers examined the consequences of these medical school closures between 1900 and 1930 for the number of county-level physicians, nurses, and midwives, and for infant, non-infant, and total mortality. The closures led to a 4% reduction in physicians per capita and resulted in declines in infant mortality, non-infant mortality, and total mortality, they found.

Insilico ranked Top50 in USA in Nature Index’s “2025 Research Leaders: Global corporate institutions for all-subject output”

InSilico Medicine
Business Announcement

The 2025 Nature Index Research Leaders rankings have been officially released. Leveraging sustained scientific breakthroughs at the intersection of biotechnology, artificial intelligence, and automation, Insilico Medicine secured a position among the Top 100 global corporate institutions for biological sciences and natural sciences publications, and ranked 43rd among global corporate institutions in the USA across all-subject output.

5
6
7
8
9